Metraipolis › archive › dc_e893796e8a29

Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges — Europe PMC PMID:42211879

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42211879
DOI
10.3389/fnbeh.2026.1833021
License (as archived)
solo-consultazione
Archived
2026-11-02T07:35:14.277Z
SHA-256 of the archived text
d78966b91167815347842610ece985d65268187f8a8a1765c8efd80eef261f16
Stable URL of this page
https://metraipolis.com/documento/dc_e893796e8a29

How to cite

Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges — Europe PMC PMID:42211879 — Europe PMC (en), https://europepmc.org/article/MED/42211879 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e893796e8a29 (Metraipolis archive dc_e893796e8a29, sha256 d78966b91167815347842610ece985d65268187f8a8a1765c8efd80eef261f16)
BibTeX
@misc{dce893796e8a29,
  title = {Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges — Europe PMC PMID:42211879},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42211879},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e893796e8a29; sha256 d78966b91167815347842610ece985d65268187f8a8a1765c8efd80eef261f16},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211879. Agents can read the archived copy with the MCP tool read_document.